Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Per Hammarström & Sofie Nyström. (2023) Viruses and amyloids - a vicious liaison. Prion 17:1, pages 82-104.
Read now
Read now
Ramya Krishna Vadlapatla, Mitesh Patel, Durga K Paturi, Dhananjay Pal & Ashim K Mitra. (2014) Clinically relevant drug–drug interactions between antiretrovirals and antifungals. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 561-580.
Read now
Read now
Pere Domingo & Francesc Vidal. (2011) Combination antiretroviral therapy. Expert Opinion on Pharmacotherapy 12:7, pages 995-998.
Read now
Read now
Articles from other publishers (29)
Huanhuan Li, Qonita Kurnia Anjani, Mary B. McGuckin, Achmad Himawan, Mingshan Li & Ryan F. Donnelly. (2023) Development of a HPLC fluorometric method for the quantification of enfuvirtide following in vitro releasing studies on thermosensitive in situ forming gel. Drug Delivery and Translational Research 13:8, pages 2183-2193.
Crossref
Crossref
Ming Fu, Yingying Xiao, Tao Du, Huimin Hu, Fengfeng Ni, Kai Hu & Qinxue Hu. (2022) Fusion Proteins CLD and CLDmut Demonstrate Potent and Broad Neutralizing Activity against HIV-1. Viruses 14:7, pages 1365.
Crossref
Crossref
Yajun Han, Manli Zhang, Ren Lai & Zhiye Zhang. (2021) Chemical modifications to increase the therapeutic potential of antimicrobial peptides. Peptides 146, pages 170666.
Crossref
Crossref
Yen-Ting Lai. (2021) Small Molecule HIV-1 Attachment Inhibitors: Discovery, Mode of Action and Structural Basis of Inhibition. Viruses 13:5, pages 843.
Crossref
Crossref
Jean-François Bruxelle, Nino Trattnig, Marianne W. Mureithi, Elise Landais & Ralph Pantophlet. (2021) HIV-1 Entry and Prospects for Protecting against Infection. Microorganisms 9:2, pages 228.
Crossref
Crossref
Zaikuan J. YuEric P. MosherNamandjé N. Bumpus. (2021) Pharmacogenomics of Antiretroviral Drug Metabolism and Transport. Annual Review of Pharmacology and Toxicology 61:1, pages 565-585.
Crossref
Crossref
Tiago N. Figueira, Marco M. Domingues, Françoise Illien, Iris Cadima-Couto, Toni Todorovski, David Andreu, Sandrine Sagan, Miguel A. R. B. Castanho, Astrid Walrant & Ana Salomé Veiga. (2019) Enfuvirtide-Protoporphyrin IX Dual-Loaded Liposomes: In Vitro Evidence of Synergy against HIV-1 Entry into Cells. ACS Infectious Diseases 6:2, pages 224-236.
Crossref
Crossref
Wenqing Lai, Chao Wang, Jun Yan, Huanliang Liu, Wei Zhang, Bencheng Lin & Zhuge Xi. (2020) Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection. Bioorganic & Medicinal Chemistry 28:4, pages 115214.
Crossref
Crossref
Chen Yuan, Jia-Ye Wang, Hai-Jiao Zhao, Yan Li, Di Li, Hong Ling & Min Zhuang. (2019) Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry. Retrovirology 16:1.
Crossref
Crossref
William C. Wimley. 2019. Antimicrobial Peptides. Antimicrobial Peptides
241
255
.
Masahiro Watanabe, Koichi Hashimoto, Yusaku Abe, Eiichi N. Kodama, Ryota Nabika, Shinya Oishi, Shinichiro Ohara, Masatoki Sato, Yukihiko Kawasaki, Nobutaka Fujii & Mitsuaki Hosoya. (2016) A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo. PLOS ONE 11:9, pages e0162823.
Crossref
Crossref
Wenqing Lai, Chao Wang, Fei Yu, Lu Lu, Qian Wang, Xifeng Jiang, Xiaoyu Xu, Tianhong Zhang, Shengming Wu, Xi Zheng, Zhenqing Zhang, Fangting Dong, Shibo Jiang & Keliang Liu. (2016) An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications. Chemical Science 7:3, pages 2145-2150.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
687
736
.
Lucia Reh, Carsten Magnus, Merle Schanz, Jacqueline Weber, Therese Uhr, Peter Rusert & Alexandra Trkola. (2015) Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent. PLOS Pathogens 11:7, pages e1004966.
Crossref
Crossref
Benjamas Aiamkitsumrit, Neil T. Sullivan, Michael R. Nonnemacher, Vanessa Pirrone & Brian Wigdahl. 2015.
257
311
.
Chao Wang, Weiguo Shi, Lifeng Cai, Lu Lu, Fei Yu, Qian Wang, Xifeng Jiang, Xiaoyu Xu, Kun Wang, Liang Xu, Shibo Jiang & Keliang Liu. (2014) Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains. Journal of Antimicrobial Chemotherapy 69:6, pages 1537-1545.
Crossref
Crossref
Mingcui Zhang, Durga Pokharel & Shiyue Fang. (2014) Purification of Synthetic Peptides Using a Catching Full-Length Sequence by Polymerization Approach. Organic Letters 16:5, pages 1290-1293.
Crossref
Crossref
Anand C. Patel. (2013) Clinical Relevance of Target Identity and Biology: Implications for Drug Discovery and Development. SLAS Discovery 18:10, pages 1164-1185.
Crossref
Crossref
Nicholas A. Meanwell, Stanley V. D'Andrea, Christopher W. Cianci, Ira B. Dicker, Kap‐Sun Yeung, Makonen Belema & Mark Krystal. 2013. Drug Discovery. Drug Discovery
439
515
.
Derry K Mercer & Deborah A O’Neil. (2013) Peptides as the next generation of anti-infectives. Future Medicinal Chemistry 5:3, pages 315-337.
Crossref
Crossref
Vanessa M.S. Duncan & Deborah A. O'Neil. (2013) Commercialization of antifungal peptides. Fungal Biology Reviews 26:4, pages 156-165.
Crossref
Crossref
Liesbet Smeulders, Lieve Bunkens, Inge Vereycken, Koen Van Acker, Pascale Holemans, Emmanuel Gustin, Marnix Van Loock & Géry Dams. 2013. Antiviral Methods and Protocols. Antiviral Methods and Protocols
11
17
.
Geoffrey Férir, Anne Hänchen, Katrien O. François, Bart Hoorelbeke, Dana Huskens, Frank Dettner, Roderich D. Süssmuth & Dominique Schols. (2012) Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120. Virology 433:2, pages 308-319.
Crossref
Crossref
Michal Maes, Abraham Loyter & Assaf Friedler. (2012) Peptides that inhibit HIV-1 integrase by blocking its protein-protein interactions. FEBS Journal 279:16, pages 2795-2809.
Crossref
Crossref
Kevin Peterson & Sarah Rowland-Jones. (2012) Article Commentary: Novel Agents for the Treatment of HIV-2 Infection. Antiviral Therapy 17:3, pages 435-438.
Crossref
Crossref
Landon R. Whitby, Kristopher E. Boyle, Lifeng Cai, Xiaoqian Yu, Miriam Gochin & Dale L. Boger. (2012) Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2861-2865.
Crossref
Crossref
Lars-Ove Brandenburg, Julika Merres, Lea-Jessica Albrecht, Deike Varoga & Thomas Pufe. (2012) Antimicrobial Peptides: Multifunctional Drugs for Different Applications. Polymers 4:1, pages 539-560.
Crossref
Crossref
John F. Kadow, David R. Langley, Nicholas A. Meanwell, Richard Pracitto, Michael A. Walker & Kap-Sun Yeung. 2012. Protein-Protein Interactions. Protein-Protein Interactions
105
165
.
Beatrice Mercorelli, David Lembo, Giorgio Palù & Arianna Loregian. (2011) Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives. Pharmacology & Therapeutics 131:3, pages 309-329.
Crossref
Crossref